Medications Versus Cognitive Behavioral Therapy in the Treatment of Depression

Medications Versus Cognitive Behavioral Therapy in the Treatment of Depression
Rachel S. Sagor
Elizabeth Pinsky
Background
Major depressive disorder (MDD) has a prevalence of approximately 9% among 12 to 17 year olds, and is associated with significant comorbidities including suicidality, long-term disease persistence, and adult psychosocial impairment.1 Standard therapy for MDD in adolescents has included selective serotonin reuptake inhibitors (SSRI) and cognitive-behavioral therapy (CBT). Adult data suggested that combination therapy led to greater symptom improvement over monotherapy; however, no such studies existed among the adolescent population.
Objectives
To compare the effectiveness of placebo vs. SSRI therapy and CBT both alone and in combination for treatment of adolescent depression.
Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Medications Versus Cognitive Behavioral Therapy in the Treatment of Depression

Full access? Get Clinical Tree

Get Clinical Tree app for offline access